In one month, voters in two states will decide, among other things, what kind of marijuana policies they want for their communities.
New Jersey and Virginia are the only two states holding gubernatorial elections this year, and the major party nominees in both races have all called for some measure of marijuana law reform.
Here’s a look at where the candidates stand…
IN BRIEF: Democratic nominee Phil Murphy, a former U.S. ambassador to Germany, wants to make the Garden State the next to legalize, regulate and tax marijuana. Republican nominee, current Lieutenant Governor Kim Guadagno, opposes legalization but supports decriminalizing possession and expanding the state’s current medical cannabis law.
PHIL MURPHY – Democrat
Murphy included a call for legalization during his primary election victory speech in June.
“The criminalization of marijuana has only served to clog our courts and cloud people’s futures, so we will legalize marijuana,” he said. “And while there are financial benefits, this is overwhelmingly about doing what is right and just.” He also pledged in the speech to end mass incarceration and “eliminate prisons for profit.”
On his campaign website, Murphy pledges to “legalize marijuana so police can focus resources on violent crimes.”
In a gubernatorial candidates’ forum he said that while legalization will generate tax revenue, his primary reason for supporting the policy is “a social justice reason.” He also alleged that the administration of current Gov. Chris Christie (R) has “gummed up” the state’s medical cannabis program.
In a general election debate, he said that legalizing cannabis should be part of “comprehensive criminal justice reform” and described ending prohibition as a “social justice” issue, citing his role as a national NAACP board member.
In another general election debate, Murphy said decriminalization isn’t enough because “the drug industry stays underground, run by the same people and it’s unregulated, so therefore minors in particular are exposed to that. But set aside the fact you don’t earn the tax revenue, which is also a reality, the fact is it remains the wild west.”
Murphy made his support for legalization clear during his primary election campaign, and often tweeted about the issue.
NJ's marijuana laws cost $143M/yr & come w a 3:1 racial disparity in arrests. As gov, Phil will legalize/tax marijuana & break this cycle. https://t.co/DIm4nRV6JH
— Phil Murphy (@PhilMurphyNJ) June 16, 2017
"I will seek to legalize marijuana & eliminate the more than 24k low-level drug arrests that bog down the courts and hurt future prospects."
— Phil Murphy (@PhilMurphyNJ) February 27, 2017
— Phil Murphy (@PhilMurphyNJ) April 27, 2017
“I was never ‘hell no,’ but I’ve spent a lot of time on it. And I have, without question, come to a place where I wasn’t three and a half years ago,” Murphy said in a New York Times interview about his evolution on marijuana. “You can’t have that many young people of color doing time on stupid drug crimes.”
KIM GUADAGNO – Republican
During a primary debate this year, Guadagno made it clear that she opposes legalization but does support some cannabis reforms.
“I have personal experience about what exactly happens to somebody who drives while they’re high, which is why I would oppose legalization of marijuana,” she said, noting that her son went to college in Colorado. “Having said that, however, I completely agree that we should decriminalize it. Because no one should suffer because of the color of their skin or because of their social background or because they were picked up with a small quantity. What that quantity is is up for argument.”
On medical cannabis, Guadagno said the state should “streamline” access and “make it easier for people that have doctors’ notes to get it and we need to provide it to children that need it the most.”
But she said that full marijuana legalization would put the state at risk of federal interference.
In a gubernatorial candidates’ forum she said legalizing marijuana would “put a whole generation of children at risk” and that ending prohibition would give her 17-year-old son an “opportunity” to use cannabis.
During a general election debate, Guadagno said she is “wholly opposed” to ending prohibition, which she described as “legalizing drug dealers.” But she said decriminalization “would solve the social justice issue.” And she would “expand the medical marijuana program,” adding: “It’s onerous, it’s hard to work with, it’s not available to those it should be made available to.”
In another general election debate, she said she won’t legalize marijuana because she’s concerned about intoxicated driving and access to kids. “I don’t want our children, I don’t want our people to walk down the street and buy a pack of cigarettes and be drug dealers,” she said.
CONTEXT: Legislative leaders in New Jersey have indicated they are prepared to enact legalization as soon as a supportive governor is seated. Currently Gov. Chris Christie (R), who is term-limited and cannot run again, is one of the nation’s most prominent opponents of ending cannabis prohibition.
IN BRIEF: Democratic nominee, current Lieutenant Governor Ralph Northam, supports decriminalizing marijuana and expanding medical cannabis access. Republican nominee Ed Gillespie, a former Republican National Committee chairman, doesn’t support those outright changes but has said he supports policies that would reduce marijuana arrests as well as enacting a more limited expansion of the state’s current low-THC medical cannabis law.
RALPH NORTHAM – Democrat
Northam has made marijuana law reform a centerpiece of his campaign, often describing the issue in racial justice terms.
“We need to change sentencing laws that disproportionately hurt people of color. One of the best ways to do this is to decriminalize marijuana,” he wrote in a blog post early this year. “African Americans are 2.8 times more likely to be arrested for marijuana possession in Virginia. The Commonwealth spends more than $67 million on marijuana enforcement — money that could be better spent on rehabilitation.”
As a physician, Northam is “increasingly convinced by the data showing potential health benefits of marijuana, such as pain relief, drug-resistant epilepsy, and treatment for PTSD,” his campaign website says. “By decriminalizing it, our researchers can better study the plant so doctors can more effectively prescribe drugs made from it.”
The lieutenant governor also sent a letter to the Virginia State Crime Commission, which is currently conducting a review of the effects of potential marijuana decriminalization. “Virginia spends $67 million on marijuana enforcement – enough to open up another 13,000 pre-K spots for children,” Northam wrote. “African Americans are nearly 3 times as likely to get arrested for simple possession of marijuana and sentencing guidelines that include jail time can all too often begin a dangerous cycle of recidivism.”
During a debate, Notham mentioned that his father is a judge while making a point about the cost of enforcing marijuana laws.
Northam has tweeted about cannabis reform a number of times.
Decriminalizing marijuana would be a good step toward helping to correct systematic racism in our justice system. https://t.co/5R7YxBJi10
— Ralph Northam (@RalphNortham) July 27, 2017
African Americans are 2.8x more likely to be arrested for marijuana than white people. Marijuana decriminalization is a racial justice issue pic.twitter.com/kmKiWul1pE
— Ralph Northam (@RalphNortham) April 5, 2017
Current marijuana laws are costly and hurt communities of color. That’s why I believe in decriminalizing it. https://t.co/tVYs3hpwX0
— Ralph Northam (@RalphNortham) August 9, 2017
As Haley's doctor, Ralph knew that access to medical marijuana was one of her best chances at a better life. pic.twitter.com/03WaKSYWLc
— Ralph Northam (@RalphNortham) April 19, 2017
Additionally, Northam supports federal cannabis rescheduling. “What would happen after that is marijuana would be reclassified and then we can look at medicinal uses,” he told HuffPost. “And the point I like to make to people is there are probably around 100 or more medicines we use routinely that come from plants. And so there are many potential uses for marijuana.”
He also backs allowing hemp cultivation. “A Northam administration will support new efforts to bring Virginia products to market, including industrial hemp processing,” his campaign website says. “Several of our key public institutions, including Virginia State University, Virginia Tech, University of Virginia and James Madison University, are conducting field research on industrial hemp [and] Virginia could explore workarounds to increase access to hemp for private growers. Additionally, at the federal level, Ralph supports the removal of industrial hemp from the Controlled Substances Act of 1970… As part of Ralph’s economic development plan, he will continue efforts to recruit an industrial hemp processor for when then federal law changes.”
ED GILLESPIE – Republican
At the start of the campaign Gillespie wasn’t on record in favor of any changes to marijuana laws. But Northam’s reform advocacy, and the response it has generated, has apparently influenced the Republican to look more seriously at the issue.
Last month Gillespie rolled out a criminal justice reform plan that includes a “Three Strikes and You’re In” policy that would allow people arrested for marijuana possession to avoid criminal charges until their third police encounter.
“This policy will reduce the number of Virginians who enter the criminal justice system and help to get treatment to more people,” Gillespie’s plan says. “Data show significant racial disparities in marijuana charges, this policy will help address them by providing opportunities to avoid entry into the criminal justice system and encouraging people to get help and reconsider their choices.”
Under the policy, cannabis would not be formally decriminalized.
Gillespie’s plan also calls for modest expansion’s to the state’s limited low-THC medical cannabis law.
“Research proves that Virginians can benefit from certain uses of marijuana to help the treatment, pain management, and healing of certain severe conditions. We owe our fellow Virginians every chance of treating and managing certain significant conditions such as cancer and epilepsy,” it says. “Ed supports appropriate, limited, tightly regulated use of marijuana for medicinal purposes based in science and on medical trials.”
State Sen. Jill Vogel, Gillespie’s lieutenant governor running mate, previously introduced legislation to add new qualifying medical conditions under the law. “Expanding safe, legal access to CBD oil and medical marijuana for seriously ill patients gives doctors another option and ensures patients aren’t forced to choose between receiving treatment and following the law,” Vogel said. “I’m proud to have taken the lead in introducing legislation in Virginia’s Senate helping expand safe, legal access for patients in need and look forward to working with my party as an advocate for this much-needed policy reform.”
In an earlier Facebook Live chat, Gillespie said, “I think there has been a growing case for tightly regulated, strictly regulated medicinal marijuana.”
Gillespie also supports allowing hemp cultivation. “Industrial hemp is a cash crop and can be found in a variety of products such as paper construction materials, food, personal care items, rope, canvas and nutritional supplements,” his campaign website says. “Ed will work with the federal government, General Assembly and licensing boards to explore industrial hemp production as an option for Virginians.”
As a Republican, Gillespie argues he is best positioned to push the federal government to modernize its approach to hemp. “Given the science and the data that we have at this point, I would be one who would be able to work with the Trump administration to be able to make the case for Virginia being one of the areas where we should be able to establish some practices and procedures for us to be able to have commercial development for industrial hemp,” he said.
CONTEXT: Virginia lawmakers considered but did not act on decriminalization legislation during the 2017 session. However, with the State Crime Commission conducting its study of the issue by the request of the Senate majority leader, its possible recommendation of removing marijuana’s criminal penalties would likely provide a significant boost to efforts to pass a bill.
Election day in both New Jersey and Virginia is Tuesday, November 7.
Photo courtesy of Democracy Chronicles.
Federal Court Dismisses Suit Against DEA Over Marijuana Growing Applications
A federal court dismissed a lawsuit against the Drug Enforcement Administration (DEA) on Friday after determining that the agency had fulfilled a requirement to process applications for research-grade marijuana manufacturers.
DEA was sued in June after declining to act on the more than two dozen applications that it received for approval to cultivate cannabis for research purposes. It’s been more than three years since the agency first announced it was opening the process to consider additional producers.
The suit, brought by the Scottsdale Research Institute (SRI), argued that the marijuana grown at the University of Mississippi—currently the only facility that’s federally authorized to cultivate the plant—is of poor quality, does not reflect the diversity of products available on the commercial market and is therefore inadequate for clinical studies.
Indeed, that’s a point that several policymakers have made, and it’s bolstered by research demonstrating that the federal government’s cannabis is genetically closer to hemp than marijuana that consumers can obtain in state-legal markets.
In July, the U.S. Court of Appeals for the District of Columbia Circuit ordered DEA to respond to the legal challenge within 30 days—and as that deadline approached in August, the agency published a notice in the Federal Register stating that it was taking steps to approve the pending applications.
Due to the volume of the applications, DEA said it would have to develop alternative rules to process them. And on Friday the court said that DEA had fulfilled its obligations and that the suit “is now moot.” While no applications have been approved to date, there’s a public comment period that will last until October 28 and then the agency will have an additional 90 days to take action on the inquiries.
“The Court dismissed our case because, according to the Court, DEA gave us the relief we had requested,” attorney Matt Zorn, who was involved in the suit, told Marijuana Moment. “Last week, on October 11, DEA published a correction to the notice it had previously published on August 26, two days before it had to respond to the Court’s order. The Court said this second notice meant there was nothing more the Court could give us.”
“The Court also declined to maintain jurisdiction over the case, because it did not find a history of chronic delay or bad faith in the record,” Zorn said. “But it also indicated that we could return to court if DEA significantly delays going forward.”
Sue Sisley, a researcher with SRI, said that despite the case being dismissed, it “moved the ball forward for everyone.”
“We would have liked to take the case one step further to ensure that all 33 applications are processed promptly—protecting the health and welfare of our nation’s medically ill patients ought to be a national priority for this administration,” she said. “By delaying these 33 applications, the administration has prevented our US scientists from investigating the clinical efficacy of real-world cannabis to treat combat veterans with PTSD. Fortunately, the Court’s order today allows us to return to court for additional relief if Trump’s DOJ/DEA continues to violate the law and put public health at risk through delay or otherwise.”
In a separate case in May, another federal court ordered DEA to “promptly” consider applications to reschedule cannabis under the Controlled Substances Act.
Read the appeals court’s ruling on the DEA marijuana application case below:
Former VA Secretary Who Oversaw Marijuana Research Blockade Now Backs Cannabis Studies For Veterans
Former U.S. Department of Veterans Affairs (VA) Secretary David Shulkin is officially on board with having the department research medical marijuana—a development that comes a year after he was in a position to actually make that happen.
In an interview with Task & Purpose that was published on Thursday, Shulkin said that “the time is now” for VA to facilitate studies into the therapeutic potential of cannabis for veterans.
“I believe that the VA should be involved in research on anything that could potentially help veterans and improve their health and well-being,” he said.
That appears to represent a notable departure from the position he held while he headed the department.
For example, VA under his leadership refused to provide assistance to an Arizona-based research facility that was soliciting veterans to participate in a federally approved clinical trial looking at the potential benefits of cannabis in the treatment of post-traumatic stress disorder (PTSD).
“Federal law restricts VA’s ability to conduct research involving medical marijuana, or to refer veterans to such research projects,” a VA official told Air Force Times in 2017. “The researcher is free to work with veterans service organizations and state veterans officials who may not face such restrictions to identify candidates for her study.”
But according to the Brookings Institute, that’s not an accurate assessment because “doctors and researchers at the VA or in VA hospitals could conduct research into the medical efficacy of marijuana while remaining completely compliant with federal laws, regulations, and the United States’ obligations under international agreements.”
While the former secretary still said during this latest interview that congressional action is necessary to prompt VA research efforts, he seems to have become decidedly more vocal about the importance of such studies as compared to his time in office.
“In particular, with the VA’s focus on suicide as the top priority, people just don’t take their lives because of no reason,” he said. “They take their lives, often because of issues related to chronic pain, depression, substance abuse, and there is growing evidence that medical marijuana—I’m not talking about recreational marijuana—but properly prescribed, may have some real benefits in anxiety improvement, in pain management, and potentially, in the issue of substance abuse.”
“And therefore, I believe it’s extremely appropriate for VA to be researching and developing therapies that can help veterans, particularly in areas where we don’t have enough good therapies or answers,” he said.
Task & Purpose followed up to ask about potential obstacles such to having VA conduct research into the issue, and Shulkin said that because marijuana is a federally controlled substance, “the challenge of doing research with the regulations, and the hoops that you have to go through, are making it too difficult to do for many of the researchers.”
“I do think that the way forward is a legislative solution, much of what VA responds to are changes in the law, where medical research for veterans in this area could be streamlined and clarity around what regulations and rules need to be followed to be able to do this research, as well as guidance about the type of research that can and should be done, which reports back to Congress.”
He added that he doesn’t anticipate that President Trump would resist legislation empowering VA to study marijuana for veterans.
Brad Burge, director of strategic communication at the Multidisciplinary Association for Psychedelic Studies (MAPS), the group behind the study into cannabis for PTSD, told Marijuana Moment that they are “pleased that Shulkin has now expressed his support for medical marijuana research, even though that support would have been much more valuable when he was still in office.”
“Nevertheless we are looking forward to the VA’s support of marijuana research and see Shulkin’s change of stance as a promising sign for veterans suffering from PTSD,” Burge said.
It wasn’t just that Shulkin’s VA put up roadblocks to cannabis research, he also resisted providing veterans with access to marijuana by declining to change internal VA policy that could empower its doctors to issue recommendations in states where it’s legal.
The reasoning, he said in 2017, is that it’s “not within our legal scope to study that in formal research programs or to prescribe medical marijuana, even in states where it’s legal” because of federal law. But advocates argued that the only thing standing in the way of VA cannabis research is VA policy itself, which Shulkin could have amended.
Getting a VA cannabis reform bill passed as the former official is now recommending has already proved difficult this year, with current VA officials voicing opposition during a congressional committee hearing in June to modest proposals such as allowing their doctors to recommend cannabis or even surveying veterans about their marijuana use.
Rep. Earl Blumenauer (D-OR) said that same month that he pulled an appropriations amendment to allow for VA marijuana recommendations from floor consideration partly because of opposition from the department.
Mexican Committees Unveil Marijuana Legalization Bill Ahead Of Supreme Court Deadline
Several Mexican Senate committees unveiled draft legislation late on Thursday to legalize marijuana.
Leaders of the Health, Justice, Public Security and Legislative Studies Committees announced last week that they would remain in permanent session to finalize the legalization bill ahead of a coming Supreme Court deadline.
The court determined last year that the country’s ban on personal cannabis consumption and cultivation is unconstitutional, though lawmakers now want to go even further by legalizing commercial production and sales.
The committees are expected to formally vote on the legislation in the coming days, after which point it will head to the full Senate and then the Chamber of Deputies. Leaders said a vote in the legislature could occur before the end of the month, though it’s possible they could ask the Supreme Court for a deadline extension.
Ayer, antes de medianoche, fue entregado a los senadores de las comisiones de Justicia, Salud, Estudios Legislativos, Segunda y Seguridad Pública el predictamen📃🌿 de la ‘Ley para la regulación de la cannabis’. Está conformado por 74 artículos y once transitorios. pic.twitter.com/8IKOF7pA1i
— Cáñamo México (@canamo_mexico) October 18, 2019
Here are some of the key provisions, according to a translation:
—Adults 18 and older can possess cannabis for personal use, cultivate up to four plants and purchase marijuana from licensed retailers.
—An independent body called the “Cannabis Institute” would be charged with issuing licenses, setting potency limits and monitoring the implementation of the law, among other responsibilities.
—Low-income individuals, small farmers and indigenous people would have licensing priority.
—Strict restrictions would be imposed on cannabis packaging. That includes requiring nondescript, standardized containers that do not feature depictions of real or fictional people or testimonials.
—Marijuana can only be consumed in private spaces.
—Only medical cannabis patients would be allowed to purchase infused edibles and beverages.
—Unregistered seeds or plants would be subject to forfeiture.
—No pesticides could be used on cannabis plants.
The bill seeks to “improve the living conditions of people living in the United Mexican States, combat the consequences of the problematic use of cannabis and reduce the crime incidence linked to drug trafficking [while] promoting peace, the security and well-being of individuals and communities,” according to the text.
Sen. Julio Menchaca Salazar, head of the Justice Committee, said in a tweet that “we are legislating to regulate the illicit market of the #marihuana and decrease the crime incidence linked to the #narcotráfico, promoting peace and security for all Mexicans.”
— Julio Menchaca S. (@Julio_Menchaca) October 18, 2019
Lawmakers have said that the legislation is largely based on a proposal that Interior Secretary Olga Sánchez Cordero filed last year while still serving as a senator, but the committees are also merging in provisions from among more than a dozen other marijuana reform bills that since have been introduced.
“They all have something good that we can be translating into law,” Menchaca Salazar, who is a member of the ruling MORENA party, said.
Debate on the measure will also be informed by findings from a series of events the Senate organized to gather public input on marijuana legalization. That includes a panel led by a former White House drug czar, who stressed the need for “robust regulations” of a legal cannabis market.
The leader of the MORENA party in the Senate, Sen. Ricardo Monreal, said earlier this month that the chamber was set to vote on a legalization bill ahead of the October 24 deadline.
“It will undoubtedly be a great discussion with the elements we have and also with all the willingness to incorporate the opinions of legislators, but it would come out this month, there are the conditions for that to be,” Menchaca Salazar said.
Read the full text of the Mexican committees’ marijuana legalization proposal below:
This story is developing and will be updated.